What Know About This Fund’s Exit From Ascendis Pharma
A notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
This piece evaluates performance in retirement for Sp 500 vs Multi Asset approaches, outlining where each may excel under different conditions.
26,383 articlesA notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
Virgin Galactic rockets Monday sparked a split in space stocks as investors rotate away from launch-focused names. Ri...
Robinhood unveils a fresh round of layoffs, cutting about 290 jobs to streamline its structure, while reporting solid...
Bitcoin steadied near the $60,000 level as tensions in the Strait of Hormuz pushed oil higher and equity futures retr...
A Google-backed study finds only 40% of U.S. workers casually use AI at work, with just 5% AI fluent. The result: big...
Ready to put $1,000 to work in AI? This beginner-friendly guide reveals a simple, diversified approach to the best st...
A leading CIO cautions that AI stock valuations may be stretched beyond sustainable growth. The article surveys what ...
Microsoft stock moved higher in a day of broad market gains. This article breaks down the top drivers behind the surg...
A high-profile insider sale sparked questions about Bandwidth and its stock. This in-depth guide explains what bandwi...
Oracle stock sinks to a fresh 52-week low as a rating downgrade raises capital-structure questions while AI ambitions...
Explore how Invitation Homes navigated Q4 2025, the drivers behind its earnings, and what savvy investors should watc...
European stocks slump as Middle East tensions lift rate expectations for the ECB and BoE, signaling a new Atlantic ri...